Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

T cell activation by autoantigens in multiple sclerosis

P Matsiota-Bernard1, E Roullet, J Ragimbeau

  • 1URA 359 du CNRS, Unité d'Immunocytochimie, Institut Pasteur, Paris, France.

Autoimmunity
|January 1, 1993
PubMed
Summary

Multiple sclerosis (MS) patients exhibit unique peripheral immune system responses to autoantigens, differing quantitatively and qualitatively from healthy individuals and those with other neurological diseases (OND). This suggests a distinct immune recognition pattern in MS.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autopolyreactivity Confers a Holistic Role in the Immune System.

Scandinavian journal of immunology·2016
Same author

A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2015
Same author

Aseptic meningitis and ischaemic stroke in Fabry disease.

International journal of clinical practice·2009
Same author

[Use of mitoxantrone in early multiple sclerosis with malignant disease course. Observational study in 30 patients with clinical and MRI outcomes after one year].

Revue neurologique·2008
Same author

Quantification of neutralizing antibodies to human type I interferons using division-arrested frozen cells carrying an interferon-regulated reporter-gene.

Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research·2008
Same author

Unexpected multiple sclerosis: follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile.

Journal of neurology, neurosurgery, and psychiatry·2008

Area of Science:

  • Immunology
  • Neuroimmunology
  • Autoimmunity

Background:

  • Multiple Sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
  • The role of peripheral immune system dysregulation in MS pathogenesis is an area of active research.
  • Understanding autoantigen recognition in MS is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate antigen recognition by peripheral blood leukocytes (PBL) in patients with active and stable MS.
  • To compare immune responsiveness in MS patients with those having other neurological diseases (OND) and healthy controls.
  • To characterize the nature of autoantigen recognition in MS.

Main Methods:

  • Analysis of peripheral blood leukocytes (PBL) from MS patients, OND patients, and healthy individuals.

Related Experiment Videos

  • In vitro assessment of cell proliferation and T-cell activation markers (interleukin-2 receptor [IL-2R] and a late activation antigen).
  • Experiments conducted with enriched T lymphocytes in the presence or absence of IL-2.

    • Main Results:

    • Autoantigen recognition was more frequent in MS patients compared to OND patients and healthy individuals.
    • In MS, recognition involved moderate proliferation or elevated IL-2R expression.
    • In OND and healthy groups, recognition primarily involved the late activation antigen.

    Conclusions:

    • The peripheral immune system in MS patients recognizes and can be activated by various autoantigens, not solely myelin basic protein (MBP).
    • The immune response in MS is quantitatively and qualitatively distinct from that observed in OND patients and healthy individuals.
    • These findings highlight a unique immunological profile in MS patients.